Companies

PETMED EXPRESS INC

PETS · CIK 0001040130 · operating

$2.73-0.72%Last updated Feb 27, 8:53 PM

Key Statistics

Valuation

Market Cap$58.64M
P/E
Fwd P/E-91.33
PEG
P/S0.31
P/B1.79
EV/EBITDA-1.12
EV/Rev0.17

Profitability

Gross Margin30.46%
Op. Margin-0.67%
Net Margin-2.76%
ROE-7.37%
ROA-4.22%
FCF Margin-0.17%

Financial Health

Current Ratio1.26
Debt/Equity0.75
Free Cash Flow-$395,000
Div. Yield

Growth & Other

Revenue Growth
EPS Growth18.92%
Beta0.72
52W High$4.46
52W Low$1.57

About PETMED EXPRESS INC

PetMed Express operates as an online pet pharmacy offering prescription and non-prescription medications, health products, and supplies for dogs, cats, and horses across the United States. The company's product portfolio includes prescription medications such as heartworm preventatives, flea and tick preventatives, arthritis treatments, dermatitis therapies, and specialty medications for conditions including thyroid disorders, diabetes, and heart/blood pressure management. Non-prescription offerings encompass flea and tick control products, bone and joint care items, vitamins, treats, nutritional supplements, hygiene products, and general household pet supplies. The company also stocks pet food, beds, crates, stairs, and related accessories.

The company distributes its products through multiple channels including its internet website, mobile application, customer support center, and direct mail marketing. This multi-channel approach allows customers to purchase medications and supplies through their preferred platforms. PetMed Express was incorporated in 1996 and maintains its headquarters in Delray Beach, Florida. The company operates with 173 full-time employees and maintains a market capitalization of $0.1 billion. Its distribution model is primarily domestic, focusing on the U.S. pet owner market.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$-0.30$-0.30+18.9%
2024$-0.37$-0.37-3800.0%
2023$0.01$0.01-96.7%
2022$0.30$1.05-11.8%
2021$0.34$1.53-2.9%
2020$0.35$1.29+9.4%
2019$0.32$1.84-36.0%
2018$0.50$1.83+35.1%
2017$0.37$1.18+37.0%
2016$0.27$1.02+8.0%
2015$0.25$0.87+8.7%
2013$0.23$0.90+0.0%
2012$0.23$0.86-71.3%
2011$0.80$0.81

Annual Reports (10-K) · 20 filings

Report DateFiledAccession Number
2025-03-312025-10-140001040130-25-000072SEC ↗
2024-03-312024-06-140001040130-24-000046SEC ↗
2023-03-312023-05-230001040130-23-000033SEC ↗
2022-03-312022-05-240001437749-22-013417SEC ↗
2021-03-312021-05-250001437749-21-013213SEC ↗
2020-03-312020-05-260001437749-20-011720SEC ↗
2019-03-312019-05-280001437749-19-010894SEC ↗
2018-03-312018-05-290001437749-18-010847SEC ↗
2017-03-312017-05-230001571049-17-005258SEC ↗
2016-03-312016-05-240001571049-16-015491SEC ↗
2015-03-312015-05-220001571049-15-004580SEC ↗
2014-03-312014-05-270001571049-14-002091SEC ↗
2013-03-312013-05-280001188112-13-001701SEC ↗
2012-03-312012-05-290001188112-12-001799SEC ↗
2011-03-312011-05-310000943440-11-000276SEC ↗
2010-03-312010-06-010000943440-10-000378SEC ↗
2009-03-312009-06-010000943440-09-000359SEC ↗
2008-03-312008-06-030000943440-08-000245SEC ↗
2007-03-312007-06-040000943440-07-000291SEC ↗
2006-03-312006-06-020000943440-06-000207SEC ↗